HopeStage
Back to all studies
CompletedNCT06164756

Long-term follow-up after ketamine treatment for Parkinson’s

About this titleRead the official source — NCT06164756
Observational studyAges 40–80United StatesDepression
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 40 years to 80 years. Other eligibility criteria applied.

Listed locations
New HavenSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateStarted: October 18, 2023
Recruitment status
Completed
Enrollment listed in the registry
49
Sponsor
Yale University
Sponsor type
University
Study type
Observational
Intervention type
Other
Locations
United States
Age range
From 40 Years to 80 Years
Official registry ID
NCT06164756
Official title
Show the full official title

Long-Term Follow-Up for Subjects Enrolled in the Ketamine for the Treatment of Depression in Parkinson's Disease (KET-PD) Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

New Haven

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Yale University, a university.

Who was this study for?

This study was for people with depression. Listed age limits: 40 years to 80 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies